首页> 外文会议>International Conference on Smart Materials and Nanotechnology in Engineering >Screening of Bile Salt Hydrolase-Active Lactic Acid Bacteria for Potential Cholesterol-Lowering Probiotic Use
【24h】

Screening of Bile Salt Hydrolase-Active Lactic Acid Bacteria for Potential Cholesterol-Lowering Probiotic Use

机译:胆汁盐水解酶 - 活性乳酸菌的筛选,用于降低胆固醇降低益生菌使用

获取原文

摘要

Cholesterol-lowering effect of lactic acid bacteria (LAB) with bile salt hydrolase activity is well known. In this study, 150 LAB were screened for bile salt deconjugation ability and probiotic characters. Fourteen isolates with higher bile salt deconjugation ability were initially screened out using deconjugation rate above 50% as standard. These isolates were further screened for adhesion to HT-29 cells, bile tolerance and acid resistance. Four isolates, namely Lactobacillus casei F0822, Lactobacillus casei F0422, Enterococcus faecium F0511 and Enterococcus faecium IN7.12, was finally screened out. The 4 isolates may be able to reduce serum cholesterol levels in human and thus have a potential to apply in the biomedicine field.
机译:乳酸菌(实验室)与胆汁盐水解酶活性的胆固醇降低效果是众所周知的。在本研究中,筛选了150例实验室用于胆汁盐剥离能力和益生菌特征。最初使用低于50%以上的脱鸡速度筛选含有较高含盐脱盐的能力的14个分离物。进一步筛选这些分离物以粘附到HT-29细胞,胆耐受性和耐酸性。四个分离株,即乳杆菌酪虫F0822,Lactobacillus caseI F0422,肠球菌FAECIUM F0511和肠球菌FAECIUMIUMINIM IN7.12,筛选出来。 4个分离物可能能够减少人中的血清胆固醇水平,因此具有施加在生物医学领域的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号